Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
William Harbour
University of Miami School of Medicine, Department: Ophthalmology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Castle Biosciences
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
Dr. Harbour is an inventor of intellectual property (IP) used in the NIH-funded research. The IP is licensed to Castle Biosciences. Dr.Harbour also consults for Castle Biosciences.
Molecular Predictive Testing in Ocular Melanoma
Project Narrative In previous funding periods of this grant, we developed a highly innovative gene expression profile-based prognostic test for uveal melanoma that is now the widely used first-in-class industry standard in the field. We have since discovered new prognostically significant mutations in BAP1 and SF3B1 and a new mRNA biomarker (PRAME) that will set a new standard for prognostic accuracy, while also guiding the choice of systemic therapy. In this competitive renewal, we propose a landmark prospective 28-center study to optimize and validate these new biomarkers, and to develop a ground breaking new prognostic test based on circulating exosomal microRNA profiling performed on routine blood samples, which will greatly expand the number of patients with uveal melanocytic tumors who will benefit from personalized genomic medicine.
Filed on April 11, 2017.
Tell us what you know about William Harbour's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
William Harbour filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| William Harbour | University of Miami School of Medicine | Conflict of Interest | Castle Biosciences | $10,000 - $19,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.